Fractured dexamethasone implant (OZURDEX®) following intravitreal injection

Dexamethasone implant (Ozurdex™) is a relatively safe medication with few adverse events can happen. We demonstrate clinical course and images of a rare case of fractured intravitreal Ozurdex™ implant that observed immediately following injection and its final outcome.

Detalles Bibliográficos
Autores principales: Aljohani, Saud M., Al-Shehri, Abdulaziz M., Al-Rubaie, Khalid R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Clinical Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597817/
https://www.ncbi.nlm.nih.gov/pubmed/34880586
http://dx.doi.org/10.4103/ojo.ojo_31_21
_version_ 1784600676302585856
author Aljohani, Saud M.
Al-Shehri, Abdulaziz M.
Al-Rubaie, Khalid R.
author_facet Aljohani, Saud M.
Al-Shehri, Abdulaziz M.
Al-Rubaie, Khalid R.
author_sort Aljohani, Saud M.
collection PubMed
description Dexamethasone implant (Ozurdex™) is a relatively safe medication with few adverse events can happen. We demonstrate clinical course and images of a rare case of fractured intravitreal Ozurdex™ implant that observed immediately following injection and its final outcome.
format Online
Article
Text
id pubmed-8597817
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-85978172021-12-07 Fractured dexamethasone implant (OZURDEX®) following intravitreal injection Aljohani, Saud M. Al-Shehri, Abdulaziz M. Al-Rubaie, Khalid R. Oman J Ophthalmol Clinical Image Dexamethasone implant (Ozurdex™) is a relatively safe medication with few adverse events can happen. We demonstrate clinical course and images of a rare case of fractured intravitreal Ozurdex™ implant that observed immediately following injection and its final outcome. Wolters Kluwer - Medknow 2021-10-20 /pmc/articles/PMC8597817/ /pubmed/34880586 http://dx.doi.org/10.4103/ojo.ojo_31_21 Text en Copyright: © 2021 Oman Ophthalmic Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Clinical Image
Aljohani, Saud M.
Al-Shehri, Abdulaziz M.
Al-Rubaie, Khalid R.
Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
title Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
title_full Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
title_fullStr Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
title_full_unstemmed Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
title_short Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
title_sort fractured dexamethasone implant (ozurdex®) following intravitreal injection
topic Clinical Image
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597817/
https://www.ncbi.nlm.nih.gov/pubmed/34880586
http://dx.doi.org/10.4103/ojo.ojo_31_21
work_keys_str_mv AT aljohanisaudm fractureddexamethasoneimplantozurdexfollowingintravitrealinjection
AT alshehriabdulazizm fractureddexamethasoneimplantozurdexfollowingintravitrealinjection
AT alrubaiekhalidr fractureddexamethasoneimplantozurdexfollowingintravitrealinjection

Ejemplares similares